Executive Summary The Amphotericin B Prices witnessed a modest yet steady upward movement across key global markets during the quarter ending December 2025. The global antifungal pharmaceutical segment continued to experience constrained supply conditions, firm procurement patterns, and ongoing logistics pressures. Across North America, Asia-Pacific (APAC), and Europe, the Amphotericin B Price Index recorded quarterly increases ranging between 0.51% and 0.56%, indicating ti
